The following is a list of what is included in the item above. Click the test(s) below to view what biomarkers are measured along with an explanation of what the biomarker is measuring.
Also known as: CBC, CBC includes Differential and Platelets, CBC/PLT w/DIFF, Complete Blood Count (includes Differential and Platelets)
NOTE: Ulta Lab Tests provides CBC test results from Quest Diagnostics as they are reported. Often, different biomarker results are made available at different time intervals. When reporting the results, Ulta Lab Tests denotes those biomarkers not yet reported as 'pending' for every biomarker the test might report. Only biomarkers Quest Diagnostics observes are incorporated and represented in the final CBC test results provided by Ulta Lab Tests.
Also known as: Chem 12, Chemistry Panel, Chemistry Screen, CMP, Complete Metabolic Panel, Comprehensive Metabolic Panel CMP, SMA 12, SMA 20
Also known as: A1c, Glycated Hemoglobin, Glycohemoglobin, Glycosylated Hemoglobin, HA1c, HbA1c, Hemoglobin A1c, Hemoglobin A1c HgbA1C, Hgb A1c
Also known as: Iron and TIBC, Iron and Total Iron Binding Capacity TIBC, TIBC
Also known as: Lipid Panel with Ratios (fasting), Lipid Profile with Ratios (fasting), Lipids
Also known as: Reverse T3, Reverse Triiodothyronine, RT3, T3 Reverse RT3 LCMSMS, Triiodothyronine Reverse
Also known as: Triiodothyronine
Also known as: Free T3, FT3, T3 Free
Also known as: T4 Thyroxine Total
Also known as: Free T4, FT4, T4 Free
Also known as: Thyroid Stimulating Hormone, Thyroid Stimulating Hormone (TSH), Thyrotropin
Also known as: B12, B12 Vitamin, Cobalamin, Cyanocobalamin, Vitamin B12 Cobalamin
The TH-2. Hyperthyroidism panel contains 13 tests with 78 biomarkers.
Brief Description: The TH-2 Hyperthyroidism panel is a comprehensive diagnostic tool designed to assess the function of the thyroid gland and identify conditions leading to hyperthyroidism. It goes beyond basic thyroid hormone assessments to include a wide range of tests that evaluate the overall health and potential complications associated with hyperthyroidism.
Collection Method: Blood Draw
Specimen Type: Whole Blood and Serum
Test Preparation: Patient should be fasting 9-12 hours prior to collection.
Collection should be done in the morning.
Specifc to TSH: Specimen collection after fluorescein dye angiography should be delayed for at least 3 days. For patients on hemodialysis, specimen collection should be delayed for 2 weeks.
According to the assay manufacturer Siemens: "Samples containing fluorescein can produce falsely depressed values when tested with the Advia Centaur TSH3 Ultra assay."
The TH-2 Hyperthyroidism panel is typically ordered for individuals exhibiting symptoms of hyperthyroidism, such as unexplained weight loss, rapid heartbeat, increased appetite, anxiety, and heat intolerance. It's also used to monitor the effectiveness of treatments in patients with known hyperthyroid conditions and to evaluate the potential systemic effects of hyperthyroidism on the body.
While the TH-2 Hyperthyroidism panel offers a broad overview of thyroid function and its systemic impacts, the TH-3 and TH-4 panels provide deeper insights, particularly into the autoimmune aspects of thyroid disease.
TH-3 Hyperthyroidism Panel: Adds thyroid antibody tests, such as Thyroid Peroxidase Antibodies and Thyroglobulin Antibodies, which are essential for diagnosing autoimmune thyroid conditions like Graves' disease. The inclusion of Vitamin B6 further aids in assessing neurological health and metabolic function.
TH-4 Hyperthyroidism Panel: The most comprehensive, TH-4 includes all tests in TH-3 and introduces TSH Receptor Binding Antibody and Thyroid Stimulating Immunoglobulin tests, specific for Graves' disease and other autoimmune thyroid disorders, providing a thorough assessment of the disease's etiology and guiding treatment.
The TH-2 Hyperthyroidism panel is designed to diagnose hyperthyroidism and assess its effects on the body. It can help identify Graves' disease, toxic nodular goiter, and thyroiditis by evaluating thyroid hormone levels and their impact on metabolic functions. The panel also aids in detecting and managing complications associated with hyperthyroidism, such as osteoporosis, cardiovascular disease, and diabetes.
Healthcare professionals use the results from the TH-2 Hyperthyroidism panel to diagnose hyperthyroidism, identify its cause, and evaluate its systemic effects. Elevated thyroid hormones with suppressed TSH typically confirm hyperthyroidism. The comprehensive metabolic assessments help manage related conditions, ensuring a holistic approach to treatment and monitoring.
The TH-2 Hyperthyroidism panel is a valuable diagnostic tool for evaluating hyperthyroidism and its broader health implications. By assessing thyroid function in conjunction with metabolic and nutritional status, healthcare providers can gain a holistic view of the patient's health, guiding effective treatment strategies. For those requiring further evaluation, particularly in autoimmune thyroid diseases, the TH-3 and TH-4 panels offer additional diagnostic capabilities to tailor treatment approaches more precisely.
We advise having your results reviewed by a licensed medical healthcare professional for proper interpretation of your results.